18.04.2013
- Actelion shareholders rejected a $5.6 million pay award for the biotechnology company's chief executive Jean-Paul Clozel on Thursday, making it the second Swiss company in as many...
18.04.2013
- Syngenta, the world's largest maker of crop chemicals, expects farmers to continue to invest in products to boost agricultural output despite a recent drop in commodity prices...
16.04.2013
- Actelion, Europe's largest biotech company, said it may return to profit growth sooner than expected after its first-quarter earnings more than doubled and sales of its mainstay...
15.04.2013
- Life Technologies has accepted a $13.6 billion cash buyout proposal from scientific and laboratory instruments company Thermo Fisher Scientific in one of the year's biggest...
13.04.2013
- Even as U.S. officials this week awaited the arrival of a sample of the new bird flu virus from China - typically the first step in making a flu vaccine - government-backed...
12.04.2013
- Swiss drugmaker Roche has no plans to change its holding in Japan's Chugai Pharmaceutical and the recent weakening of the yen would not be a reason to trigger such a move. Asked if...
12.04.2013
- U.S. investment firm Royalty Pharma is considering sweetening its $6.6 billion offer for Irish drugmaker Elan by paying Elan shareholders more if the multiple sclerosis drug...
11.04.2013
- The Rise Of Generics - In 2011, CMS Pharma was invited to take part in a conference in Mumbai to discuss the emergence of "supergenerics," a new form of generic drugs with improved...
11.04.2013
- A spike in U.S. demand for flu drug Tamiflu and strong sales of mainstay cancer medicines lifted first-quarter sales at Roche by a bigger-than-expected 5%. The healthy performance...
11.04.2013
- Biotech firms eager to push drug candidates through clinical trials prompted an overall increase in R&D expenditure of 20% in just a year, research and consulting firm GlobalData...
